evaxion Biotech
-
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
COPENHAGEN, Denmark, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion" or the "Company"), a clinical-stage TechBio company specializing in developing AI-Immunology
powered vaccines, announces an expanded commitment to developing tailored cancer vaccines by targeting a novel category of AI-identified tumor antigens, named Endogenous Retroviruses (ERVs).The new treatment opportunity may broaden the applicability of cancer vaccines. Through the new vaccine targets, ERVs, treating patients unresponsive to conventional cancer immunotherapy may become possible. With the elevated focus on this groundbreaking therapeutic concept, Evaxion has initiated preclinical activities with a goal of generating Proof-of-Concept data by the second half of 2024.
Evaxion's Chief Scientific Officer, Birgitte Rønø, expresses optimism, "With our intensified focus on ERV cancer vaccines, we aim to expedite the development process to deliver treatment solutions to cancer patients who, until now, have been deemed unresponsive to immunotherapy. The ERV cancer vaccine targets represent a promising breakthrough that could significantly broaden the horizons of cancer vaccine applicability and marks a significant step forward in our commitment to improving healthcare through innovative and AI-powered approaches. We are already seeing significant interest in ERV-based vaccines and look forward to further underpinning the significant potential by these Proof-of-Concept data."
-
Jo, tror på Evaxion. Men +137% i dag har ikke noget med virksomheden at gøre. Ja, de har en spændende pipeline, men de har også kæmpe finansieringsudfordringer. Derfor risiko for udvanding i år, og det vil presse kursen nedad frem mod phase-II resultaterne i Q3. Andet vil være mærkeligt. Tror den falder ned i det der 6-7 dollarleje igen inden alt for længe, og så samler jeg op igen. Det var ligesom det markedet ville give for den inden splittet, og intet har ændret sig efter splittet.
Du skal huske på, at Evaxion gerne vil give kursen noget medvind inden de udsteder nye aktier. Reverse-split, dagens nyheder om ny 'banebrydende' platform (som er i helt indledende fase) og om Mercks 11% stake - det er jo planlagt med håb om at få lidt interesse og volume i aktien igen. Vi står over for et stadigt usikkert aktieår, og det er ikke låntagernes tider... Renterne er stadig høje, og det vil de med høj sandsynlighed fortsat være i et stykke tid. Makro giver modvind, også selvom pipelinen er spændende.
-
Ligner pump and dump.
-
-
Video om Evaxion: - Steg 220% på kun 3 dage - og jeg har aktien!
https://www.youtube.com/watch?v=NVyRx3naRFg -
Luften gik ud...wisuwa....pump and dump
24% ned nu
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind